Aldesleukin Terminated Phase 4 Trials for Liver Diseases / Transplantations Treatment

IndicationsStatusPurposePhase
TerminatedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02949492Low-dose IL-2 for Treg Expansion and Tolerance (LITE)